Markulan L, Makarevych L. Pembrolizumab as an immunotherapy drug in the treatment of a patient with recurrent (unresectable) cancer of the lower lip. ЗХ [Internet]. 2022Dec.30 [cited 2024Nov.22];(2):75-82. Available from: http://generalsurgery.com.ua/article/view/270978